Madagascar vs Mozambique: Population requiring preventive chemotherapy for schistosomiasis
Madagascar
13.03 million
in 2024
Mozambique
18.41 million
in 2024
Madagascar rank
6th
Mozambique rank
4th
Population requiring preventive chemotherapy for schistosomiasis over time
- Madagascar
- Mozambique
How they compare
Mozambique currently reports 18.41 million against 13.03 million in Madagascar, a difference of 5.38 million.
That makes Mozambique's figure about 1.4 times Madagascar's.
Across all 15 years both countries report, Mozambique has been ahead every year.
Madagascar ranks 6th and Mozambique ranks 4th of 52 countries.
Mozambique has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Madagascar | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.86 million | 13.93 million | 6.07 million | Mozambique |
| 2020s | 11.30 million | 18.10 million | 6.80 million | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Madagascar or Mozambique?
- Mozambique, at 18.41 million against 13.03 million in Madagascar as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Madagascar and Mozambique?
- 5.38 million, with Mozambique ahead.
- How many years of comparable data are there for Madagascar and Mozambique?
- 15 years are reported by both, from 2010 to 2024.
- How do Madagascar and Mozambique rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Madagascar ranks 6th and Mozambique ranks 4th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.